Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factor X for Surgery in Factor X Deficiency
NCT01086852Phase 3Terminated
- Sponsor
- Bio Products Laboratory
- Start
- Mar 2011
- Primary completion
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
Phase 3, open-label, single-arm trial of coagulation factor X human in factor X deficiency (FXD), sponsored by Bio Products Laboratory. Primary endpoints: Clinical Estimation of Volume of Blood Loss During Surgery, Clinical Assessment of Blood Loss During Surgery Against the Volume of Blood Loss Expected in Patients Without a Bleeding Disorder and 4 more. Started Mar 2011; status: terminated.
02
Drugs
coagulation factor X human
03
Conditions
factor X deficiency (FXD)
Beyond the preview
Go deeper on NCT01086852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01086852.